Glucose‐lowering pharmacotherapies in Chinese adults with type 2 diabetes and cardiovascular disease or chronic kidney disease. An expert consensus reported by the Chinese Diabetes Society and the Chinese Society of Endocrinology-Reference-Cited by-同舟云学术

Glucose‐lowering pharmacotherapies in Chinese adults with type 2 diabetes and cardiovascular disease or chronic kidney disease. An expert consensus reported by the Chinese Diabetes Society and the Chinese Society of Endocrinology

Published:2020-11-23 Issue:4 Volume:37 Page:
ISSN:1520-7552
Container-title:Diabetes/Metabolism Research and Reviews
language:en
Short-container-title:Diabetes Metab Res Rev

Author:

Hong Tianpei¹^ORCID,Su Qing²,Li Xiaoying³,Shan Zhongyan⁴,Chen Li⁵^ORCID,Peng Yongde⁶,Chen Liming⁷,Yan Li⁸,Bao Yuqian⁹,Lyu Zhaohui¹⁰,Shi Lixin¹¹,Wang Weiqing¹²,Guo Lixin¹³,Ning Guang¹²,Mu Yiming¹⁰,Zhu Dalong¹⁴

Affiliation:

1. Department of Endocrinology and Metabolism Peking University Third Hospital Beijing China

2. Department of Endocrinology Xinhua Hospital Shanghai Jiao Tong University School of Medicine Shanghai China

3. Department of Endocrinology and Metabolism Zhongshan Hospital Fudan Univeristy Shanghai China

4. Department of Endocrinology The First Hospital of China Medical University Shenyang China

5. Department of Endocrinology Qilu Hospital of Shangdong University Jinan China

6. Department of Endocrinology and Metabolism Shanghai General Hospital Shanghai Jiao Tong University Shanghai China

7. Department of Endocrinology Chu Hisen‐I Memorial Hospital Tianjin Medical University Tianjin China

8. Department of Endocrinology Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou China

9. Department of Endocrinology and Metabolism Shanghai Jiao Tong University Affiliated Sixth People's Hospital Shanghai China

10. Department of Endocrinology The First Medical Center of Chinese PLA General Hospital Beijing China

11. Department of Endocrinology The Affiliated Hospital of Guizhou Medical University Guiyang China

12. Department of Endocrinology and Metabolism Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai China

13. Department of Endocrinology Beijing Hospital National Center of Gerontology Institute of Geriatric Medicine Chinese Academy of Medical Sciences Beijing China

14. Department of Endocrinology Drum Tower Hospital Affiliated to Nanjing University Medical School Nanjing China

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/dmrr.3416

Reference77 articles.

1. Standards of medical care for type 2 diabetes in China 2019

2. 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2020

3. Associations of Diabetes Mellitus With Total Life Expectancy and Life Expectancy With and Without Cardiovascular Disease

4. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017

5. Prevalence of Established Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in the UK

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dapagliflozin improves pancreatic islet function by attenuating microvascular endothelial dysfunction in type 2 diabetes;Diabetes/Metabolism Research and Reviews;2022-12-30

2. A Retrospective Study of the Perioperative Period Management of Joint Arthroplasty in Patients with Chronic Kidney Disease;Orthopaedic Surgery;2022-12

3. Rho/Rho Kinase Signaling Pathway and Disease: from Bed to Bench;Frontiers in Cardiovascular Drug Discovery;2022-11-09

4. The Influence of Public Mental Health Based on Artificial Intelligence Technology on the Teaching Effect of Business Administration Major;Journal of Environmental and Public Health;2022-09-09

5. The Prevalence of Cardiovascular Disease in Adults with Type 2 Diabetes in China: Results from the Cross-Sectional CAPTURE Study;Diabetes Therapy;2022-03-21